|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.952 AED | -1.04% |
|
-4.61% | +23.80% |
| 05-09 | Gulf Pharmaceutical Industries to Temporarily Halt Trading in Abu Dhabi on May 14 | MT |
| 03-21 | Gulf Pharmaceutical Industries Shares to be Suspended Ahead of Annual General Meeting | MT |
Gulf Pharmaceutical Industries P.S.C. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was AED 1,143.2 million compared to AED 573 million a year ago. Net income was AED 64.4 million compared to net loss of AED 293.2 million a year ago.
Basic earnings per share was AED 0.056 compared to basic loss per share of AED 0.277 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +23.80% | 299M | |
| +7.22% | 72.5B | |
| +13.69% | 9.11B | |
| -11.75% | 5.07B | |
| +59.61% | 5.01B | |
| +2.62% | 3.85B | |
| -17.54% | 2.46B | |
| +21.35% | 2.44B | |
| -27.82% | 2.26B | |
| +25.13% | 2.27B |
GULF PHARMACEUTICAL INDUSTRIES 
